AVROBIO, Inc

(NASDAQ:AVRO)

Latest On AVROBIO, Inc (AVRO):

Date/Time Type Description Signal Details
2023-05-22 19:14 ESTNewsAvrobio up 69% on plans to sell gene therapy program to NovartisN/A
2023-05-11 17:07 ESTNewsAVROBIO GAAP EPS of -$0.57 misses by $0.01N/A
2023-05-01 19:41 ESTNewsAVROBIO appoints interim CEON/A
2023-03-23 15:51 ESTNewsAVROBIO GAAP EPS of -$0.57 misses by $0.12N/A
2023-02-08 18:58 ESTNewsAvrobio jumps 78% amid speculation of takeover interestN/A
2022-11-09 02:49 ESTNewsAVROBIO GAAP EPS of -$0.52 beats by $0.01N/A
2022-10-27 22:14 ESTNewsAvrobio stock rises on FDA rare pediatric disease tag for Gaucher disease gene therapyN/A
2022-10-18 16:06 ESTNewsAvrobio rises as gene therapy for Gaucher disease gets ILAP designation in UKN/A
2022-09-20 13:00 ESTNewsAvrobio stock rises as kidney disease gene therapy gets FDA rare pediatric disease statusN/A
2022-09-14 19:03 ESTNewsAvrobio stock rises as gene therapy for rare disorder cleared to enter pediatric trial in UKN/A
2022-08-09 19:17 ESTNewsAVROBIO GAAP EPS of -$0.64 misses by $0.09N/A
2022-07-13 12:54 ESTNewsAVROBIO granted FDA’s orphan drug designation for metabolic disorder therapyN/A
2022-07-09 22:05 ESTNewsStocks To Watch: Bank Earnings, Amazon Prime Day, Nano Labs IPO, And Ferroglobe EventN/A
2022-05-18 03:36 ESTNewsAvrobio stock rises as gene therapy for rare disorder shows promise in interim data from trialN/A
2022-05-11 00:41 ESTNewsAVROBIO GAAP EPS of -$0.68 misses by $0.11N/A
2022-03-18 12:59 ESTNewsAVROBIO GAAP EPS of -$0.65 beats by $0.10N/A
2022-02-15 01:01 ESTNewsAVROBIO (AVRO) Presents At AVROBIO WORLD Symposium 2022 CystinosisN/A
2022-02-10 04:10 ESTNewsAVROBIO gains after interim data from cystinosis study for gene therapyN/A
2022-02-07 18:24 ESTNewsAVROBIO Inc. (AVRO) Reprioritizes Pipeline Programs, Presentation - SlideshowN/A
2022-02-04 17:31 ESTNewsAvrobio announces inducement grants to three new employeesN/A
2022-01-06 09:24 ESTNewsAVROBIO grants non-statutory stock options to three new employeesN/A
2022-01-04 09:44 ESTNewsAVROBIO to deprioritize Fabry disease programN/A
2021-11-05 01:47 ESTNewsAVROBIO EPS in-lineN/A
2021-11-03 08:33 ESTNewsAVROBIO gets FDA Rare Pediatric Disease status for Hunter syndrome treatment AVR-RD-05N/A
2021-11-02 12:34 ESTNewsWarning: AVRO is at high risk of performing badlyN/A
2021-10-26 12:52 ESTNewsAVROBIO picks internal candidate for chief medical officerN/A
2021-10-20 03:13 ESTNewsAVROBIO shares interim safety data for gene therapy asset in Fabry disease, Gaucher diseaseN/A
2021-10-07 05:25 ESTNewsAVROBIO to present safety data from Fabry disease, Gaucher disease trialsN/A
2021-09-21 12:58 ESTNewsAvrobio (AVRO) Investor Presentation - SlideshowN/A
2021-08-09 23:47 ESTNewsBluebird bio’s setback hurts AVROBIO and others focused on lentiviral gene therapiesN/A
2021-08-05 22:44 ESTNewsAVROBIO EPS misses by $0.08N/A
2021-07-20 21:03 ESTNewsAVROBIO initiated buy at Needham; estimates more than $2 billion peak sales from pipelineN/A
2021-07-20 20:45 ESTNewsAfter recent weakness, gene therapy space offers a compelling opportunity: BTIGN/A
2021-05-05 12:07 ESTNewsAVROBIO: Fabrazyme's Full Approval Changes ThingsN/A
2021-03-18 14:41 ESTNewsAVROBIO EPS beats by $0.17N/A
2021-03-11 03:24 ESTNewsBluebird bio upgraded to buy at Mizuho on safety updateN/A
2021-03-10 11:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $34.5 to $32.86.Neutral
2021-03-03 11:10 ESTAnalyst RatingThe Analyst Target Price has decreased from $38.6 to $34.5.Neutral
2021-03-01 07:14 ESTAnalyst RatingThe Analyst Target Price has increased from $36.67 to $38.6.Buy
2021-02-19 11:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $38.43 to $36.67.Neutral
2021-02-18 11:15 ESTNewsAvrobio: An Update After Stock Price Drop After bluebird Trial HaltN/A
2021-02-17 00:03 ESTNewsBluebird bio trial suspension hurts Orchard and AVROBION/A
2021-02-12 15:05 ESTNewsAVROBIO (AVRO) Presents At 17th Annual Virtual WORLDSymposium 2021 - SlideshowN/A
2021-02-10 07:28 ESTNewsAvrobio reports 100% kidney substrate reduction with plato gene therapy in Fabry disease, shares up 20%N/A
2021-02-10 07:11 ESTAnalyst RatingThe Analyst Target Price has increased from $36.71 to $38.43.Buy
2021-01-15 07:10 ESTAnalyst RatingThe Analyst Target Price has decreased from $37.86 to $36.71.Neutral
2021-01-02 15:10 ESTFinancialsCompany financials have been released.Neutral
2020-12-26 20:13 ESTNewsAvrobio: 3 Promising Phase 1/2 Therapeutics, $220M In Cash, And 2021 CatalystsN/A
2020-12-25 11:58 ESTNewsAVROBIO: Undercovered Gene Therapy Developer With Excellent PromiseN/A
2020-12-13 03:16 ESTFinancialsCompany financials have been released.Neutral

About AVROBIO, Inc (AVRO):

AVROBIO, Inc., a clinical-stage gene therapy company, focuses on developing ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose in the United States. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene, which is defective in the target disease. The company's lead product candidate is AVR-RD-01, which is in ongoing Phase II clinical trial and investigator-sponsored Phase I clinical trial for the treatment of Fabry disease. It is also developing AVR-RD-02 that has completed pre-clinical trials for the treatment of type 1 Gaucher disease; AVR-RD-03, which is in preclinical development to treat Pompe disease; and AVR-RD-04 that has completed pre-clinical studies for treating cystinosis. The company has a research and clinical collaboration agreement with Magenta Therapeutics to evaluate targeted antibody-drug conjugate as a conditioning regimen for lentiviral gene therapies. AVROBIO, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

AVRO Quotes by TradingView

See Advanced Chart

General

  • Name AVROBIO, Inc
  • Symbol AVRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 123
  • Fiscal Year EndDecember
  • IPO Date2018-06-21
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.avrobio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.73
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.87
  • Return on Assets -32%
  • Return on Equity -55%
  • Earnings Per Share -$2.54
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 530.16 million
  • EBITDA -62516000
  • Analyst Target Price $32.86
  • Book Value Per Share $5.70
View More

Share Statistics

  • Shares Outstanding 41.45 million
  • Shares Float 29.31 million
  • % Held by Insiders 240%
  • % Held by Institutions 92.09%
  • Shares Short 3.31 million
  • Shares Short Prior Month 2.98 million
  • Short Ratio 3.83
  • Short % of Float 9%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.36
  • 52 Week High $23.5
  • 52 Week Low $10.25
  • 50 Day Moving Average 13.42
  • 200 Day Moving Average 14.52
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

AVROBIO, Inc (AVRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

AVROBIO, Inc (AVRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$1.01-$0.80-26.52%
2020-06-302020-08-06$N/A-$0.80-$0.76-5.26%
2020-03-312020-05-07$N/A-$0.77-$0.66-17.56%
2019-12-312020-03-16$N/A-$0.72-$0.59-21.52%
2019-09-302019-11-07$N/A-$0.57-$0.570.51%
2019-06-302019-08-08$N/A-$0.67-$0.7611.34%
2019-03-312019-05-13$N/A-$0.72-$0.71-2.13%
2018-12-312019-03-25$N/A-$0.67-$0.56-18.94%
2018-09-302018-11-13$N/A-$0.49-$0.9950.51%
2018-06-302018-08-09$N/A-$0.44-$0.475.88%

AVROBIO, Inc (AVRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

AVROBIO, Inc (AVRO) Chart:

AVROBIO, Inc (AVRO) News:

Below you will find a list of latest news for AVROBIO, Inc (AVRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

AVROBIO, Inc (AVRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-04-192.50.05CALL6 70FALSE00
2024-04-1950.05CALL0 20FALSE00
2024-04-197.50CALL0 00FALSE00
2024-04-192.50PUT0 0548.27TRUE00
2024-04-1950PUT0 0383.76TRUE00
2024-04-197.50PUT0 0659.59TRUE00
2024-05-172.50.05CALL5 920FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 0167TRUE00
2024-05-1750PUT0 0264.05TRUE00
2024-05-177.50PUT0 0419.34TRUE00
2024-08-162.50.05CALL1 76387.48FALSE00
2024-08-1650CALL0 00FALSE00
2024-08-167.50CALL0 00FALSE00
2024-08-162.51.6PUT0 1135.56TRUE00
2024-08-1650PUT0 0192.72TRUE00
2024-08-167.50PUT0 0266.26TRUE00
2024-11-152.50CALL0 00FALSE00
2024-11-1550CALL0 00FALSE00
2024-11-157.50CALL0 00FALSE00
2024-11-152.50PUT0 0148.91TRUE00
2024-11-1550PUT0 0158.24TRUE00
2024-11-157.50PUT0 0218.11TRUE00

Latest AVRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$1.03
Jun 13, 2022 7:59 PM EST100$1.03
Jun 13, 2022 7:59 PM EST700$1.03
Jun 13, 2022 7:59 PM EST100$1.03
Jun 13, 2022 7:59 PM EST100$1.05

AVROBIO, Inc (AVRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000156459020029433/0001564590-20-029433-index.htm
2019-07-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1681087/000000000019010742/0000000000-19-010742-index.htm
2019-12-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1681087/000000000019016808/0000000000-19-016808-index.htm
2020-01-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000001961720000136/0000019617-20-000136-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000083423720008031/0000834237-20-008031-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318017787/0000899243-18-017787-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318017963/0000899243-18-017963-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318017964/0000899243-18-017964-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318017965/0000899243-18-017965-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318017968/0000899243-18-017968-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318017975/0000899243-18-017975-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318026507/0000899243-18-026507-index.htm
2018-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318026516/0000899243-18-026516-index.htm
2018-12-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318031418/0000899243-18-031418-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924318031419/0000899243-18-031419-index.htm
2019-01-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319000536/0000899243-19-000536-index.htm
2019-01-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319000538/0000899243-19-000538-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319000539/0000899243-19-000539-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319000540/0000899243-19-000540-index.htm
2019-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319000840/0000899243-19-000840-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319000842/0000899243-19-000842-index.htm
2019-01-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319001171/0000899243-19-001171-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319001495/0000899243-19-001495-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319006669/0000899243-19-006669-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319010373/0000899243-19-010373-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319010377/0000899243-19-010377-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319014418/0000899243-19-014418-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319016853/0000899243-19-016853-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319016854/0000899243-19-016854-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319016855/0000899243-19-016855-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319016856/0000899243-19-016856-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319016858/0000899243-19-016858-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319016860/0000899243-19-016860-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319020100/0000899243-19-020100-index.htm
2019-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924319020101/0000899243-19-020101-index.htm
2020-01-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924320002356/0000899243-20-002356-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924320004179/0000899243-20-004179-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924320004181/0000899243-20-004181-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924320004746/0000899243-20-004746-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000089924320004749/0000899243-20-004749-index.htm
2018-07-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000092963818000615/0000929638-18-000615-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000092963819000273/0000929638-19-000273-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000092963820000326/0000929638-20-000326-index.htm
2018-07-05SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1681087/000107261318000404/0001072613-18-000404-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000110465920021707/0001104659-20-021707-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220009825/0001127602-20-009825-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220009831/0001127602-20-009831-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220009836/0001127602-20-009836-index.htm
2020-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220009839/0001127602-20-009839-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220009841/0001127602-20-009841-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220009843/0001127602-20-009843-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220019012/0001127602-20-019012-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220019015/0001127602-20-019015-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220019017/0001127602-20-019017-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220019020/0001127602-20-019020-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220019024/0001127602-20-019024-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220019028/0001127602-20-019028-index.htm
2020-10-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220027387/0001127602-20-027387-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000112760220027388/0001127602-20-027388-index.htm
2018-06-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000114420418035942/0001144204-18-035942-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000114420419007205/0001144204-19-007205-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1681087/000114420419008323/0001144204-19-008323-index.htm
2019-07-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1681087/000114420419036699/0001144204-19-036699-index.htm
2018-06-21424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1681087/000119312518199473/0001193125-18-199473-index.htm
2018-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312518199489/0001193125-18-199489-index.htm
2018-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312518202460/0001193125-18-202460-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312518243524/0001193125-18-243524-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000119312518243527/0001193125-18-243527-index.htm
2018-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312518281353/0001193125-18-281353-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312518288547/0001193125-18-288547-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312518324912/0001193125-18-324912-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000119312518325511/0001193125-18-325511-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312518356370/0001193125-18-356370-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519003876/0001193125-19-003876-index.htm
2019-01-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1681087/000119312519006212/0001193125-19-006212-index.htm
2019-01-118-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519007398/0001193125-19-007398-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519013423/0001193125-19-013423-index.htm
2019-01-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1681087/000119312519017226/0001193125-19-017226-index.htm
2019-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519028978/0001193125-19-028978-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519084287/0001193125-19-084287-index.htm
2019-03-2510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1681087/000119312519085321/0001193125-19-085321-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312519085335/0001193125-19-085335-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312519085348/0001193125-19-085348-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1681087/000119312519120864/0001193125-19-120864-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1681087/000119312519120871/0001193125-19-120871-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519123672/0001193125-19-123672-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519144763/0001193125-19-144763-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000119312519145337/0001193125-19-145337-index.htm
2019-05-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1681087/000119312519154392/0001193125-19-154392-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519170745/0001193125-19-170745-index.htm
2019-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1681087/000119312519187439/0001193125-19-187439-index.htm
2019-07-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1681087/000119312519190535/0001193125-19-190535-index.htm
2019-07-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519193574/0001193125-19-193574-index.htm
2019-07-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1681087/000119312519194771/0001193125-19-194771-index.htm
2019-07-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1681087/000119312519195743/0001193125-19-195743-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519195748/0001193125-19-195748-index.htm
2019-08-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1681087/000119312519213159/0001193125-19-213159-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519216001/0001193125-19-216001-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519263223/0001193125-19-263223-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312519286594/0001193125-19-286594-index.htm
2019-11-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312519289914/0001193125-19-289914-index.htm
2019-12-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1681087/000119312519320892/0001193125-19-320892-index.htm
2019-12-20S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1681087/000119312519320919/0001193125-19-320919-index.htm
2019-12-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312519320938/0001193125-19-320938-index.htm
2020-01-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1681087/000119312520000692/0001193125-20-000692-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1681087/000119312520005416/0001193125-20-005416-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520005881/0001193125-20-005881-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520029771/0001193125-20-029771-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1681087/000119312520033439/0001193125-20-033439-index.htm
2020-02-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1681087/000119312520035569/0001193125-20-035569-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520035577/0001193125-20-035577-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520073732/0001193125-20-073732-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312520074925/0001193125-20-074925-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520091030/0001193125-20-091030-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520097126/0001193125-20-097126-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520135565/0001193125-20-135565-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520141026/0001193125-20-141026-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520142191/0001193125-20-142191-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520211298/0001193125-20-211298-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1681087/000119312520211325/0001193125-20-211325-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520263234/0001193125-20-263234-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520264387/0001193125-20-264387-index.htm
2020-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520273355/0001193125-20-273355-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000119312520286214/0001193125-20-286214-index.htm
2019-07-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000120919119043593/0001209191-19-043593-index.htm
2019-07-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000120919119043594/0001209191-19-043594-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1681087/000120919120010413/0001209191-20-010413-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000156459019030417/0001564590-19-030417-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000156459019041704/0001564590-19-041704-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1681087/000156459020011144/0001564590-20-011144-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1681087/000156459020017934/0001564590-20-017934-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1681087/000156459020017940/0001564590-20-017940-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000156459020022815/0001564590-20-022815-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000156459020028774/0001564590-20-028774-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000156459020029433/0001564590-20-029433-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1681087/000156459020031761/0001564590-20-031761-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000156459020037237/0001564590-20-037237-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1681087/000156459020051456/0001564590-20-051456-index.htm
2019-07-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1681087/999999999519001560/9999999995-19-001560-index.htm
2020-01-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1681087/999999999520000091/9999999995-20-000091-index.htm

AVROBIO, Inc (AVRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AVROBIO, Inc (AVRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 240%
Institutional Ownership: 9209%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-10-08Katina DortonChief Financial OfficerBuy10,000.000.919,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1681087/000089924318026516/0000899243-18-026516-index.htm
2019-01-02Erik OstrowskiChief Financial OfficerBuy2,300.002,300.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319000539/0000899243-19-000539-index.htm
2020-02-11CHRISTOPHER PAIGEDirectorSell15,000.0028.00420,000.00252,512.00https://www.sec.gov/Archives/edgar/data/1681087/000089924320004181/0000899243-20-004181-index.htm
2020-01-28CHRISTOPHER PAIGEDirectorSell10,000.0023.00230,000.00267,512.00https://www.sec.gov/Archives/edgar/data/1681087/000089924320002356/0000899243-20-002356-index.htm
2019-04-08CHRISTOPHER PAIGEDirectorSell100.0026.922,692.00277,512.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319010377/0000899243-19-010377-index.htm
2019-04-08CHRISTOPHER PAIGEDirectorSell2,400.0025.8462,021.28277,612.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319010377/0000899243-19-010377-index.htm
2019-04-05CHRISTOPHER PAIGEDirectorSell867.0026.2122,723.81280,012.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319010377/0000899243-19-010377-index.htm
2019-04-05CHRISTOPHER PAIGEDirectorSell6,633.0025.59169,759.03280,879.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319010377/0000899243-19-010377-index.htm
2018-10-08NERISSA KREHERChief Medical OfficerBuy2,942.000.912,677.222,942.00https://www.sec.gov/Archives/edgar/data/1681087/000089924318026507/0000899243-18-026507-index.htm
2020-02-12GEOFFREY MACKAYOfficerSell1,400.0029.0740,691.98345,123.00https://www.sec.gov/Archives/edgar/data/1681087/000089924320004746/0000899243-20-004746-index.htm
2020-02-11GEOFFREY MACKAYOfficerSell18,404.0028.10517,099.03346,523.00https://www.sec.gov/Archives/edgar/data/1681087/000089924320004179/0000899243-20-004179-index.htm
2020-02-11GEOFFREY MACKAYOfficerSell44,596.0027.361,219,981.55364,927.00https://www.sec.gov/Archives/edgar/data/1681087/000089924320004179/0000899243-20-004179-index.htm
2019-04-08GEOFFREY MACKAYOfficerSell698.0027.0718,893.25409,523.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319010373/0000899243-19-010373-index.htm
2019-04-05GEOFFREY MACKAYOfficerSell13,302.0027.26362,617.84410,221.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319010373/0000899243-19-010373-index.htm
2019-07-19Atlas Venture Fund X, L.P.10% Share HolderBuy810,811.0018.5015,000,003.505,567,289.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319020101/0000899243-19-020101-index.htm
2019-07-19Bruce BoothDirectorBuy810,811.0018.5015,000,003.505,567,289.00https://www.sec.gov/Archives/edgar/data/1681087/000089924319020100/0000899243-19-020100-index.htm